277 related articles for article (PubMed ID: 26621566)
1. Relationship Among Strongyloides stercoralis Infection, Human T-Cell Lymphotropic Virus Type 1 Infection, and Cancer: A 24-Year Cohort Inpatient Study in Okinawa, Japan.
Tanaka T; Hirata T; Parrott G; Higashiarakawa M; Kinjo T; Kinjo T; Hokama A; Fujita J
Am J Trop Med Hyg; 2016 Feb; 94(2):365-370. PubMed ID: 26621566
[TBL] [Abstract][Full Text] [Related]
2. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological aspects of Strongyloides stercoralis infection in Okinawa, Japan.
Arakaki T; Kohakura M; Asato R; Ikeshiro T; Nakamura S; Iwanaga M
J Trop Med Hyg; 1992 Jun; 95(3):210-3. PubMed ID: 1597879
[TBL] [Abstract][Full Text] [Related]
4. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan.
Hayashi J; Kishihara Y; Yoshimura E; Furusyo N; Yamaji K; Kawakami Y; Murakami H; Kashiwagi S
Am J Trop Med Hyg; 1997 Jan; 56(1):71-5. PubMed ID: 9063365
[TBL] [Abstract][Full Text] [Related]
5. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
6. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.
Salles F; Bacellar A; Amorim M; Orge G; Sundberg M; Lima M; Santos S; Porto A; Carvalho E
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560
[TBL] [Abstract][Full Text] [Related]
7. Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies).
Agapé P; Copin MC; Cavrois M; Panelatti G; Plumelle Y; Ossondo-Landeau M; Quist D; Grossat N; Gosselin B; Fenaux P; Wattel E
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(4):394-402. PubMed ID: 10096585
[TBL] [Abstract][Full Text] [Related]
8. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Ashida C; Kinoshita K; Nozaki Y; Funauchi M
BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
[TBL] [Abstract][Full Text] [Related]
9. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica.
Robinson RD; Lindo JF; Neva FA; Gam AA; Vogel P; Terry SI; Cooper ES
J Infect Dis; 1994 Mar; 169(3):692-6. PubMed ID: 8158055
[TBL] [Abstract][Full Text] [Related]
10. Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers?
Arakaki T; Asato R; Ikeshiro T; Sakiyama K; Iwanaga M
Trop Med Parasitol; 1992 Sep; 43(3):199-200. PubMed ID: 1470843
[TBL] [Abstract][Full Text] [Related]
11. Secondary Strongyloides stercoralis prophylaxis in patients with human T-cell lymphotropic virus type 1 infection: report of two cases.
Peters L; McCarthy AE; Faught C
Int J Infect Dis; 2009 Nov; 13(6):e501-3. PubMed ID: 19501008
[TBL] [Abstract][Full Text] [Related]
12. Strongyloides stercoralis: a rare and severe presentation in a pregnant woman.
Beltrán Rosel A; Sanjoaquín Conde I; Pérez Muñoz A; Alcalá PM; Marta CB; Irigoyen von Sierakowski A
New Microbiol; 2020 Jan; 43(1):44-46. PubMed ID: 31814031
[TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of Strongyloides stercoralis infection among HTLV-I infected blood donors in Barcelona, Spain: A cross-sectional study.
Salvador F; Sulleiro E; Piron M; Sánchez-Montalvá A; Sauleda S; Molina I
Acta Trop; 2017 Dec; 176():412-414. PubMed ID: 28939495
[TBL] [Abstract][Full Text] [Related]
14. Coinfection by Strongyloides stercoralis in blood donors infected with human T-cell leukemia/lymphoma virus type 1 in São Paulo City, Brazil.
Chieffi PP; Chiattone CS; Feltrim EN; Alves RC; Paschoalotti MA
Mem Inst Oswaldo Cruz; 2000; 95(5):711-2. PubMed ID: 10998221
[TBL] [Abstract][Full Text] [Related]
15. Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.
Satoh M; Futami A; Takahira K; Kodaira M; Tanaka T; Kuriki K; Hori E
J Infect Chemother; 2003 Dec; 9(4):355-7. PubMed ID: 14691660
[TBL] [Abstract][Full Text] [Related]
16. Strongyloidiasis and infective dermatitis alter human T lymphotropic virus-1 clonality in vivo.
Gillet NA; Cook L; Laydon DJ; Hlela C; Verdonck K; Alvarez C; Gotuzzo E; Clark D; Farré L; Bittencourt A; Asquith B; Taylor GP; Bangham CR
PLoS Pathog; 2013; 9(4):e1003263. PubMed ID: 23592987
[TBL] [Abstract][Full Text] [Related]
17. Association between Strongyloides stercoralis infection and biliary tract cancer.
Hirata T; Kishimoto K; Kinjo N; Hokama A; Kinjo F; Fujita J
Parasitol Res; 2007 Oct; 101(5):1345-8. PubMed ID: 17611780
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic study of the association between human T-cell lymphotropic virus type 1 and Strongyloides stercoralis infection in female blood donors (Guadeloupe, French West Indies).
Courouble G; Rouet F; Herrmann-Storck C; Nicolas M; Candolfi E; Deloumeaux J; Carme B
West Indian Med J; 2004 Jan; 53(1):3-6. PubMed ID: 15114885
[TBL] [Abstract][Full Text] [Related]
19. Disseminated Strongyloides stercoralis infection in HTLV-1-associated adult T-cell leukemia/lymphoma.
Stewart DM; Ramanathan R; Mahanty S; Fedorko DP; Janik JE; Morris JC
Acta Haematol; 2011; 126(2):63-7. PubMed ID: 21474923
[TBL] [Abstract][Full Text] [Related]
20. Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1.
Satoh M; Kiyuna S; Shiroma Y; Toma H; Kokaze A; Sato Y
Clin Exp Immunol; 2003 Sep; 133(3):391-6. PubMed ID: 12930366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]